Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Avni Joshi

Clinical trials sponsored by Avni Joshi, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could a common supplement help rare lung disease? Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

Could a common supplement help rare lung disease?

Disease control Ongoing

This phase 2 trial tests whether the supplement fisetin can improve lung disease in people with common variable immunodeficiency (CVID). Twenty participants will receive either fisetin or a placebo on four days over a month. The study measures changes in immune cells and lung fun…

Phase 2 • Sponsor: Avni Joshi • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC